Other
Orthognathic Surgery
0
Pipeline Programs↗
5
Active Trials↗
0
Companies Involved↗
Orthognathic Surgery is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
19
clinical trials
Completed8 · 42%
Unknown status3 · 16%
Active, not recruiting2 · 11%
Withdrawn2 · 11%
Not yet recruiting1 · 5%
Recruiting1 · 5%
Other2 · 11%
Clinical Trials
Trial Activity
19 trials
Antibiotics for Prevention of Infection Following Orthognathic Surgery
Recruiting·—·Phase 4·NCT05852158·400 enrolled
A Cohort Prospective Study of Predictors Influencing the Quality of Visualization of the Operating Field During Orthognathic Surgery
Enrolling by invitation·State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia·N/A·NCT05814991·100 enrolled
Effects of Antiemetic Agents in Orthognathic Surgery Patients
Completed·—·Phase 4·NCT06454825·66 enrolled
Prospective Evaluation of Perioperative Steroid Dosing on Postsurgical Edema in Orthognathic Surgery
Completed·—·Phase 4·NCT03190642·180 enrolled
Does it Worth to Reinforce With Additional Anesthesia to Improve Postoperative Course After Orthognathic Surgery?
Completed·—·Phase 2·NCT03974035·52 enrolled
Effect of Steroid for the Postoperative Swelling After Orthognathic Surgery
Completed·—·Phase 4·NCT01431014·56 enrolled
Nasal Septum Autologous Chondrocytes Transplantation for Condylar Resorption After Orthognathic Surgery
Completed·FFaculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp Neto·Phase 1·NCT03137914·10 enrolled
Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery
Withdrawn·—·Phase 4·NCT03318757
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)